Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 25, Issue 12, Pages 1077-1093Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14728222.2021.2015321
Keywords
Pancreatic cancer; aerobic glycolysis; key enzymes; c-Myc; HIF-1A; signaling pathways; Non-coding RNAs
Categories
Ask authors/readers for more resources
Aerobic glycolysis plays a crucial role in PDAC, with regulatory networks involving key factors such as c-Myc, HIF-1α, mTOR pathway, and non-coding RNAs. Experimental evidence suggests that modulators or inhibitors of aerobic glycolysis have therapeutic effects in tumor models, yet clinical translation remains a challenge.
Introduction: Glycometabolic rearrangements (aerobic glycolysis) is a hallmark of pancreatic ductal adenocarcinoma (PDAC) and contributes to tumorigenesis and progression through numerous mechanisms. The targeting of aerobic glycolysis is recognized as a potential therapeutic strategy which offers the possibility of improving treatment outcomes for PDAC patients. Areas covered: In this review, the role of aerobic glycolysis and its regulatory networks in PDAC are discussed. The targeting of aerobic glycolysis in PDAC is examined, and its therapeutic potential is evaluated. The relevant literature published from 2001 to 2021 was searched in databases including PubMed, Scopus, and Embase. Expert opinion: Regulatory networks of aerobic glycolysis in PDAC are based on key factors such as c-Myc, hypoxia-inducible factor 1 alpha, the mammalian target of rapamycin pathway, and non-coding RNAs. Experimental evidence suggests that modulators or inhibitors of aerobic glycolysis promote therapeutic effects in preclinical tumor models. Nevertheless, successful clinical translation of drugs that target aerobic glycolysis in PDAC is an obstacle. Moreover, it is necessary to identify the potential targets for future interventions from regulatory networks to design efficacious and safer agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available